Connect your AI

Treace Medical Concepts, Inc. TMCI Price / book

Price / book at other companies

Johnson & JohnsonJNJ

7.3×+2.1×

CONMEDCNMD

1.1×-0.8×

Zimmer Biomet HoldingsZBH

1.4×-0.4×

EnovisENOV

0.9×+0.1×

OrthoPediatricsKIDS

1.2×-0.5×

Orthofix Medical Inc.OFIX

1.1×-0.3×

Other financials

Income statement

Revenue$47.2M-10.2%

Gross profit$37.4M-10.7%

Operating income-$17.2M-10.2%

Net income-$18.0M-12.8%

EPS (diluted)-$0.28-12.0%

Balance sheet

Cash & equivalents$9.5M-28.6%

Total debt$71.6M+3.2%

Total equity$77.2M-26.7%

Total assets$184.1M-10.6%

Cash flow

Operating cash flow$7.2M+72.5%

CapEx$3.1M-13.6%

Free cash flow$4.2M+538%

Valuation

Market cap$258.19M-26.6%

Enterprise value$320.25M-22.6%

P/S1.3×-0.4×

Profitability

Gross margin79.7%-0.5pp

Operating margin-26.9%+2.5pp

Net margin-29.4%+6.1pp

FCF margin-12.5%-2.8pp

Returns & leverage

Return on equity-66.9%+57.5pp

Debt / equity0.9×+0.3×

Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

market cap/total stockholders equity=1.1×

Based on the most recent quarter.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Treace Medical Concepts, Inc.'s price / book?: Treace Medical Concepts, Inc. (TMCI) reported price / book of 1.1× in Q1 2026.
How has Treace Medical Concepts, Inc.'s price / book changed year-over-year?: Treace Medical Concepts, Inc.'s price / book decreased by 77.5% year-over-year, from 5× to 1.1×.
What is the long-term trend for Treace Medical Concepts, Inc.'s price / book?: Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s price / book has grown at a -36.5% compound annual growth rate (CAGR), from 11× to 1.8×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.